Voora, D <br/><br/>
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Apr 2010 
 - 445-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Validation Study 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2009.291  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Black or African American--genetics<br/>Aged<br/>Alleles<br/>Anticoagulants--administration & dosage<br/>Calcium-Binding Proteins--genetics<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Mixed Function Oxygenases--metabolism<br/>Polymorphism, Single Nucleotide<br/>Vitamin K Epoxide Reductases<br/>Warfarin--administration & dosage<br/>White People--genetics